Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders

NCT02540538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: HBVaxPro
BIOLOGICAL: HBAI20

Sponsor

Maastricht University Medical Center

Collaborators

[object Object]